(Q74267792)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Induction of HLA-A2-restricted CTL responses by a tubular structure carrying human melanoma epitopes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Mrinal K Ghosh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Cui-Ling Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Catherine Fayolle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Gilles Dadaglio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Aileen Murphy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

François A Lemonnier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Claude Leclerc

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

19-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

2463-2473

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

Human tumor antigens recognized by T cells

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Cancer vaccines based on the identification of genes encoding cancer regression antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Induction of protective antiviral cytotoxic T cells by a tubular structure capable of carrying large foreign sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

DNA sequencing with chain-terminating inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Cross-presentation, dendritic cells, tolerance and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Differential effects of flanking residues on presentation of epitopes from chimeric peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900185-8

7 January 2021

10.1016/S0264-410X(02)00185-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference